HBM HOLDINGS-B Shares Surge on AI Drug Discovery Venture Announcement

Stock News06-17

Shares of HBM HOLDINGS-B (02142) have risen more than 5%. At the time of writing, the stock is up 5.34% to HK$10.66, with a turnover of HK$11.05 million.

The increase follows a recent company announcement detailing a new strategic partnership. HBM HOLDINGS-B has entered into a comprehensive, long-term strategic collaboration with BioMap. The partnership is centered on using artificial intelligence (AI) to discover and develop complex large-molecule drugs. The goal is to systematically overcome key bottlenecks in developing next-generation innovative therapies and jointly build a globally competitive AI research and development ecosystem.

Key Details of the Strategic Alliance

Under the strategic cooperation framework, HBM HOLDINGS-B and BioMap will co-establish a new-generation AI pipeline R&D company named MegaStream TechBio (MegaStream). This new entity will be focused on the global market.

MegaStream will integrate "exclusive big data × proprietary large models × a large portfolio of innovative pipelines." It aims to build an AI R&D engine centered on an advanced, integrated intelligent dry-wet lab closed-loop experimental discovery platform and personalized, multi-modal, multi-attribute generative large models.

Focus Areas for the New Venture

MegaStream will concentrate on major unmet clinical needs in areas such as cardiovascular disease, kidney disease, oncology, and anti-aging. Its core R&D benchmarks will be to develop First-in-Class (FIC) and Best-in-Class (BIC) assets.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1144425345?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-17 10:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1144425345","market":"us","top_or_hot":-1,"title":"HBM HOLDINGS-B Shares Surge on AI Drug Discovery Venture Announcement","media":"Stock News","content":"<p>Shares of <b>HBM HOLDINGS-B (02142)</b> have risen more than 5%. At the time of writing, the stock is up 5.34% to HK$10.66, with a turnover of HK$11.05 million.<br><br>\nThe increase follows a recent company announcement detailing a new strategic partnership. <b>HBM HOLDINGS-B</b> has entered into a comprehensive, long-term strategic collaboration with BioMap. The partnership is centered on using artificial intelligence (AI) to discover and develop complex large-molecule drugs. The goal is to systematically overcome key bottlenecks in developing next-generation innovative therapies and jointly build a globally competitive AI research and development ecosystem.<br><br>\n<b>Key Details of the Strategic Alliance</b><br><br>\nUnder the strategic cooperation framework, <b>HBM HOLDINGS-B</b> and BioMap will co-establish a new-generation AI pipeline R&D company named MegaStream TechBio (MegaStream). This new entity will be focused on the global market.<br><br>\nMegaStream will integrate \"exclusive big data × proprietary large models × a large portfolio of innovative pipelines.\" It aims to build an AI R&D engine centered on an advanced, integrated intelligent dry-wet lab closed-loop experimental discovery platform and personalized, multi-modal, multi-attribute generative large models.<br><br>\n<b>Focus Areas for the New Venture</b><br><br>\nMegaStream will concentrate on major unmet clinical needs in areas such as cardiovascular disease, kidney disease, oncology, and anti-aging. Its core R&D benchmarks will be to develop First-in-Class (FIC) and Best-in-Class (BIC) assets.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HBM HOLDINGS-B Shares Surge on AI Drug Discovery Venture Announcement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHBM HOLDINGS-B Shares Surge on AI Drug Discovery Venture Announcement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-17 10:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of <b>HBM HOLDINGS-B (02142)</b> have risen more than 5%. At the time of writing, the stock is up 5.34% to HK$10.66, with a turnover of HK$11.05 million.<br><br>\nThe increase follows a recent company announcement detailing a new strategic partnership. <b>HBM HOLDINGS-B</b> has entered into a comprehensive, long-term strategic collaboration with BioMap. The partnership is centered on using artificial intelligence (AI) to discover and develop complex large-molecule drugs. The goal is to systematically overcome key bottlenecks in developing next-generation innovative therapies and jointly build a globally competitive AI research and development ecosystem.<br><br>\n<b>Key Details of the Strategic Alliance</b><br><br>\nUnder the strategic cooperation framework, <b>HBM HOLDINGS-B</b> and BioMap will co-establish a new-generation AI pipeline R&D company named MegaStream TechBio (MegaStream). This new entity will be focused on the global market.<br><br>\nMegaStream will integrate \"exclusive big data × proprietary large models × a large portfolio of innovative pipelines.\" It aims to build an AI R&D engine centered on an advanced, integrated intelligent dry-wet lab closed-loop experimental discovery platform and personalized, multi-modal, multi-attribute generative large models.<br><br>\n<b>Focus Areas for the New Venture</b><br><br>\nMegaStream will concentrate on major unmet clinical needs in areas such as cardiovascular disease, kidney disease, oncology, and anti-aging. Its core R&D benchmarks will be to develop First-in-Class (FIC) and Best-in-Class (BIC) assets.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VXUS","symbol_name":"国际股票ETF-Vanguard","start_time":0,"source_url":"","article_id":"1144425345","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1144425345","pubTimestamp":1781664505,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Shares of HBM HOLDINGS-B (02142) have risen more than 5%. At the time of writing, the stock is up 5.34% to HK$10.66, with a turnover of HK$11.05 million. The increase follows a recent company...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"VXUS":"国际股票ETF-Vanguard","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","BK4588":"碎股","BK1161":"生物科技","BK4585":"ETF&股票定投概念","AGIX":"通用人工智能 ETF-AGIX","BK1574":"生物医药B类股","ARTY":"ISHARES FUTURE AI & TECH ETF","BK1583":"高瓴概念","02142":"和铂医药-B","AIPO":"Defiance AI and Power Infrastructure ETF"},"translate_title":"HBM HOLDINGS-B股因人工智能药物发现项目公告而飙升","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ARTY":1,"AIPO":1,"CHAT":1,"02142":1,"AGIX":1,"VXUS":1},"content_text":"Shares of HBM HOLDINGS-B (02142) have risen more than 5%. At the time of writing, the stock is up 5.34% to HK$10.66, with a turnover of HK$11.05 million.\nThe increase follows a recent company announcement detailing a new strategic partnership. HBM HOLDINGS-B has entered into a comprehensive, long-term strategic collaboration with BioMap. The partnership is centered on using artificial intelligence (AI) to discover and develop complex large-molecule drugs. The goal is to systematically overcome key bottlenecks in developing next-generation innovative therapies and jointly build a globally competitive AI research and development ecosystem.\nKey Details of the Strategic Alliance\nUnder the strategic cooperation framework, HBM HOLDINGS-B and BioMap will co-establish a new-generation AI pipeline R&D company named MegaStream TechBio (MegaStream). This new entity will be focused on the global market.\nMegaStream will integrate \"exclusive big data × proprietary large models × a large portfolio of innovative pipelines.\" It aims to build an AI R&D engine centered on an advanced, integrated intelligent dry-wet lab closed-loop experimental discovery platform and personalized, multi-modal, multi-attribute generative large models.\nFocus Areas for the New Venture\nMegaStream will concentrate on major unmet clinical needs in areas such as cardiovascular disease, kidney disease, oncology, and anti-aging. Its core R&D benchmarks will be to develop First-in-Class (FIC) and Best-in-Class (BIC) assets.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1144425345","isCrawlerRequest":true}